Beacon Biosignals

📍 Boston, United States🗓 Founded 2019👥 133 employees💰 Last funded Feb 2026
Software Development🌐 beacon.bio
Website LinkedIn
Beacons AI platform for brain data enables and accelerates new treatments that transform the lives of patients with neurological and psychiatric disease. Through FDA-cleared EEG wearables, novel machine learning algorithms, enormous datasets, and advances in software engineering, we are changing the way patients are treated for disorders of the brain. Want to join the team? We’re hiring—check out the careers page on our website for more. Please be advised that Beacon Biosignals does not ask for personal information outside of our official hiring process. If a role is not listed on our careers page, it is not an active job opening. We will never ask candidates to send money to supplement company equipment, and all official emails from our team will come from the @beacon.bio domain, never text messages or Teams messages.
5
Total investors
3
Early stage
0
Mid stage
2
Late stage
2019
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2019–2026 · investors recorded per year
20192202112025120261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Beacon Biosignals?
Beacon Biosignals has 5 investors on record on gritt.io, including 3 early-stage backers and 2 late-stage investors.
When did Beacon Biosignals last raise funding?
The most recent investment in Beacon Biosignals recorded on gritt.io was in February 2026.
When was Beacon Biosignals founded?
Beacon Biosignals was founded in 2019.
What industry is Beacon Biosignals in?
Beacon Biosignals operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Beacon Biosignals based?
Beacon Biosignals is headquartered in Boston, United States.